Fludarabine-based disease-specific conditioning or conventional myeloablative conditioning in hematopoietic stem cell transplantation for treatment of non-malignant diseases

Fludarabine-based conditioning (FBC) was given to 24 patients and conventional myeloablative conditioning (MC) to 33 patients, most children, before hematopoietic stem cell transplantation (HSCT) for non-malignant diseases. The donors were human leukocyte antigen (HLA)-A, -B, -DRbeta1-identical rela...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Bone marrow transplantation (Basingstoke) 2007-04, Vol.39 (7), p.383-388
Hauptverfasser:	RINGDEN, O, REMBERGER, M, BARKHOLT, L, WINIARSKI, J, LJUNGMAN, P, MATTSSON, J, SVENBERG, P, SVAHN, B.-M, DAHLLÖF, G, GUSTAFSSON, B, HASSAN, Z, OMAZIC, B, UZUNEL, M, ASCHAN, J
Format:	Artikel
Sprache:	eng
Schlagworte:	Adolescent Adult Alopecia Anemia, Aplastic - therapy Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy Antigens Antineoplastic Agents - pharmacology Bacteremia Bilirubin Biological and medical sciences Bone marrow Bone marrow, stem cells transplantation. Graft versus host reaction Care and treatment CD3 antigen Child Child, Preschool Children Chimerism Conditioning Female Fever Fludarabine Graft versus host disease Graft vs Host Disease Graft-versus-host reaction Health aspects Health services Hematologic and hematopoietic diseases Hematopoietic Stem Cell Transplantation - methods Hematopoietic stem cells Hemoglobinopathies - therapy Histocompatibility antigen HLA Humans Immunologic Deficiency Syndromes - therapy Infant Leukemia Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis Leukocytes Male Medical sciences Middle Aged Mucositis Patients Physiological aspects Renal function Stem cell transplantation Stem cells Survival Transfusions. Complications. Transfusion reactions. Cell and gene therapy Transplantation Transplantation Conditioning Vidarabine - analogs & derivatives Vidarabine - pharmacology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!